Deal typeM&A & Private Equity & Transaction Services
IndustryLife Sciences
The BDO Life Sciences M&A team has advised the shareholders of G&L Healthcare Advisors in connection with a majority investment from Armira, a leading investment holding providing entrepreneurial capital for entrepreneurial partnerships with a long-term horizon.
Founded in 2016, G&L Healthcare Advisors are a leading, international provider of regulatory, quality and compliance services to the pharmaceutical and biotech industries. With global capabilities across the US, EU and India, G&L have longstanding relationships with a diverse client base including many of the top 10 pharma companies.
This is the BDO Life Sciences team's third recent deal in the regulatory consulting space, a fast-growing segment of the market that continues to benefit from a broad range of tailwinds. As part of the deal, BDO also provided vendor financial due diligence, vendor tax due diligence, and financial modelling services.
“We have worked with the BDO Life Sciences M&A team over many years and on a number of transactions. With this transaction they have again helped us achieve a fantastic result. BDO ensured a smooth process from start to finish, with their expert, professional advice and clear sector knowledge invaluable throughout. We look forward to working with them again in the future.”
Stephen Loughrey and Peter Griffin, Founders and Chief Executive Officer / Chairman, G&L Healthcare Advisors
“BDO provided wise counsel and professional support over a long period, from the early preparation phases through to completion. Without their trusted advice and collaborative approach this transaction would not have been possible.”
Simon Keeble, Chief Financial Officer, G&L Healthcare Advisors
The BDO project team included:
Jamie Austin, Brendan Martin, Zak Holdaway, Calum McMillan, Sarah Postlethwaite, Sean Girvan (M&A)
Jeff Harris, David Wright, Luke Leney, Christian Towey (Financial due diligence)
Paul Lavercombe, Liam Hickland (Tax due diligence)
Janie Reid, Jitesh Patel, Alexa Williams, Liam Wilson (Financial modelling)
Founded in 2016, G&L Healthcare Advisors are a leading, international provider of regulatory, quality and compliance services to the pharmaceutical and biotech industries. With global capabilities across the US, EU and India, G&L have longstanding relationships with a diverse client base including many of the top 10 pharma companies.
This is the BDO Life Sciences team's third recent deal in the regulatory consulting space, a fast-growing segment of the market that continues to benefit from a broad range of tailwinds. As part of the deal, BDO also provided vendor financial due diligence, vendor tax due diligence, and financial modelling services.
“We have worked with the BDO Life Sciences M&A team over many years and on a number of transactions. With this transaction they have again helped us achieve a fantastic result. BDO ensured a smooth process from start to finish, with their expert, professional advice and clear sector knowledge invaluable throughout. We look forward to working with them again in the future.”
Stephen Loughrey and Peter Griffin, Founders and Chief Executive Officer / Chairman, G&L Healthcare Advisors
“BDO provided wise counsel and professional support over a long period, from the early preparation phases through to completion. Without their trusted advice and collaborative approach this transaction would not have been possible.”
Simon Keeble, Chief Financial Officer, G&L Healthcare Advisors
The BDO project team included:
Jamie Austin, Brendan Martin, Zak Holdaway, Calum McMillan, Sarah Postlethwaite, Sean Girvan (M&A)
Jeff Harris, David Wright, Luke Leney, Christian Towey (Financial due diligence)
Paul Lavercombe, Liam Hickland (Tax due diligence)
Janie Reid, Jitesh Patel, Alexa Williams, Liam Wilson (Financial modelling)